newsfilter
← Latest News
PR Newswire·

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International

  • Faruqi & Faruqi, LLP is investigating potential securities law violations against Baxter International Inc. (NYSE: BAX).
  • Investors who suffered losses exceeding $100,000 in Baxter stock between February 23, 2022, and July 30, 2025, are encouraged to contact partner James (Josh) Wilson.
  • The complaint alleges Baxter made false statements regarding the safety & efficacy of its Novum LVP infusion pumps, which suffered systemic defects causing malfunctions like underinfusion, overinfusion, or non-delivery.
  • Baxter allegedly failed to disclose known device defects, injuries, & deaths despite receiving notifications & implementing inadequate remedial measures.
  • The true extent of the alleged fraud was revealed on July 31, 2025, when Baxter voluntarily paused shipments & installations of the Novum LVP, causing stock to drop 22.4% to close at $21.76.
  • Investors must seek the role of lead plaintiff by the December 15, 2025, deadline in the filed federal securities class action.
  • The firm is also seeking information from whistleblowers, former employees, & shareholders regarding Baxter's conduct.
  • Attorneys at Faruqi & Faruqi, LLP have offices in New York, Pennsylvania, California, & Georgia, having recovered hundreds of millions for investors since 1995.